Smith & Nephew (LON:SN) Receives Outperform Rating from Royal Bank of Canada

Royal Bank of Canada reiterated their outperform rating on shares of Smith & Nephew (LON:SN) in a report released on Tuesday morning, MarketBeat reports. The brokerage currently has a GBX 1,500 ($18.84) target price on the stock.

Other analysts have also issued research reports about the company. Jefferies Financial Group reaffirmed a buy rating and issued a GBX 1,250 ($15.70) price target on shares of Smith & Nephew in a research note on Friday, May 3rd. Barclays reaffirmed an equal weight rating and issued a GBX 1,150 ($14.45) price target on shares of Smith & Nephew in a research note on Friday, February 9th. JPMorgan Chase & Co. raised their price target on Smith & Nephew from GBX 1,300 ($16.33) to GBX 1,381 ($17.35) and gave the stock an overweight rating in a research note on Thursday, May 2nd. Finally, Berenberg Bank reaffirmed a buy rating and issued a GBX 1,450 ($18.22) price target on shares of Smith & Nephew in a research note on Thursday, May 2nd. One analyst has rated the stock with a hold rating and five have given a buy rating to the company’s stock. Based on data from MarketBeat, the stock currently has a consensus rating of Moderate Buy and a consensus target price of GBX 1,346.20 ($16.91).

Smith & Nephew Stock Performance

LON:SN opened at GBX 997.80 ($12.54) on Tuesday. The firm has a market cap of £8.72 billion, a PE ratio of 4,153.33, a price-to-earnings-growth ratio of 0.46 and a beta of 0.51. Smith & Nephew has a fifty-two week low of GBX 887 ($11.14) and a fifty-two week high of GBX 1,316.75 ($16.54). The company has a debt-to-equity ratio of 59.11, a quick ratio of 0.84 and a current ratio of 1.77. The business has a 50 day moving average price of GBX 1,013.03 and a 200-day moving average price of GBX 1,036.71.

Smith & Nephew Increases Dividend

The company also recently disclosed a dividend, which will be paid on Wednesday, May 22nd. Shareholders of record on Thursday, March 28th will be given a dividend of $0.23 per share. The ex-dividend date of this dividend is Thursday, March 28th. This represents a yield of 1.62%. This is a positive change from Smith & Nephew’s previous dividend of $0.14. Smith & Nephew’s dividend payout ratio (DPR) is currently 12,500.00%.

Smith & Nephew Company Profile

Smith & Nephew plc, together with its subsidiaries, develops, manufactures, markets, and sells medical devices and services in the United Kingdom and internationally. It operates through three segments: Orthopaedics, Sports Medicine & ENT, and Advanced Wound Management. The company offers knee implant products for knee replacement procedures; hip implants for revision procedures; trauma and extremities products that include internal and external devices used in the stabilization of severe fractures and deformity correction procedures; and other reconstruction products.